Michael Rivner
Professor
Academic Appointment(s)
Medical College of Georgia
Department of Neurology
Emeritus Faculty
Medical College of Georgia
Department of Neuroscience and Regenerative Medicine
Administration
Department of The Graduate School
Bio
I am a specialist in Neuromuscular diseases. I established and run the ALS clinic. I have research grants in Myasthenia Gravis and ALS. I run the EMG lab at AUHealth. I also have an interest in botulinum toxins.
- MRIVNER@augusta.edu
- (706) 721-2681
- (706) 721-8701
- BP 4390
Education
-
MD, Medicine
Emory University, 1978
-
BA, Psychology, General
Duke University, 1972
-
BA, Zoology/Animal Biology
Duke University, 1972
Certifications
Courses Taught Most Recent Academic Year
-
NEUR 5000
Basic Clkshp in Neurology
-
RNEU 5004
Clinical Neurophysiology
-
NEUR 5022
EMG Elective
-
RNEU 5000
Neurology
-
NEUR 5020
Neuromuscular Disease
Teaching Interests
EMG, ALS, Myasthenia Gravis, Neuromuscular diseases, botulinum toxin
Scholarship
Selected Recent Publications
- Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-blind, placebo-controlled trial., 2025
Journal Article, Academic Journal
- Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial., 2024
Journal Article, Academic Journal
- Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study., 2024
Journal Article, Academic Journal
- Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis., 2023
Journal Article, Academic Journal
- Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis., 2021
Journal Article, Academic Journal
Research Interests
EMG
ALS
Myasthenia Gravis
Botulinum Toxins
